Stereotaxis
Manufactures robotic magnetic navigation systems for endovascular and cardiac ablation procedures.
What they do
Stereotaxis develops robotic magnetic navigation systems, including the Genesis RMN system. Electrophysiology labs and cardiovascular hospitals purchase this technology to steer catheters and guidewires through complex pathways within the heart and vascular system, minimizing radiation exposure and increasing precision during cardiac ablation therapies.
The record
- Vertical
- Devices & Robotics
- Sub-segment
- Endovascular robotics
- Product type
- Device
- Stage
- Public
- Headquarters
- St. Louis, USA
- Region
- North America
- Founded
- 1990
- Total funding
- $130M raised
Notable investors: Alafi Capital, Sanderling Ventures, OrbiMed.